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Abstract 
Adhesion molecules involved in the interaction 
between immune system effector cells and tumor targets 
are surface molecules which contribute to the formation 
of cell-to-cell contacts and belong to the integrin family. 
In this paper, the role played by the adhesion molecules 
in the process of cell-mediated cytotoxicity is reviewed. 
Furthermore, the contact area between effector and tar-
get cells has been analyzed by scanning electron micros-
copy. This region, termed "closed chamber", seems to 
contribute to killing efficiency by creating an intimate 
contact region in which cytotoxic factors can easily in-
duce lethal hit in target cell. Thus, the extension of the 
closed chamber seems to be positively related to effector 
cell killing potential as well as to target cell sensitivity 
and, in this context, the adhesion molecules prove to 
play a pivotal role. In fact, a receptor-ligand interaction 
occurs between CDlla/CD18 (LFA-1) and CD2 mole-
cules, expressed on the effector cells, and the respective 
counterparts on target cells, i.e., ICAM-1, ICAM-2, or 
LFA-3. Treatment with antibodies against such mole-
cules strongly modifies closed chamber formation with-
out inhibiting cell-to-cell binding. Nevertheless, in 
these conditions, the killing ability of different effector 
cells toward tumor targets appears to be strongly impair-
ed. Hence, the adhesion molecules seem to be strongly 
involved in the formation of the closed chamber as well 
as in the activation of effector cell killing machinery. 
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Introduction 
Cell-mediated cytotoxicity is a process mediated 
by cells of T lineage or NK lineage which ensures de-
fence against viral infection or neoplastic transforma-
tion. Cells infected by virus or expressing tumor-specif-
ic antigens can be recognized and eliminated by cytotox-
ic T cells (CTL) which specifically recognize antigens in 
the context of class I major histocompatibility complex 
(MHC) molecules. NK cells may kill virus-infected or 
transformed cells by mechanisms which are, so far, not 
defined, since these cells do not express "classic" anti-
gen receptors, such as surface lg or T cell receptor 
(TcR), and exert their cytolytic function in a MHC-unre-
stricted fashion (Savary and Lotzova, 1986; Sprent and 
Webb, 1987; Young and Cohn, 1987). 
As a general rule, cell-mediated cytotoxicity is a 
multistep process in which recognition, binding and kill-
ing of the target cells (TC) occur in sequence. MHC-un-
restricted cytotoxic cells belong predominantly to the 
NK lineage which exert their lytic activity as resting, 
freshly isolated cells (Stutman, I 981; Trinchieri and 
Perussia, 1984; Bonavida and Right, 1986; Herberman 
etal., 1986; Kang et al., 1987; Young, 1989). The cy-
totoxic potential of NK cells is enhanced by Interleukin 
2 (IL-2) stimulation which leads to the generation of the 
so-called lymphokine activated killer (LAK) cells 
(Rosemberg, 1986; Dianzani et al., 1989; Ferrini et al., 
1989). In addition, NK cytotoxicity can also be modu-
lated or enhanced by various agents (Robertson and Ritz, 
1992). 
Morphologically, most cells exhibiting NK activi-
ty as well as the LAK cell precursors of T lineage are 
characterized by the presence of cytoplasmic azurophilic 
granules and are termed large granular lymphocytes 
(LGL) (Grossi et al., 1982; Liepins et al., 1977; Grossi 
and Ferrarini, 1982). In humans, cells exhibiting NK 
function express multiple surface phenotypes. Most 
LGL (about 90 % ) are represented by cells of CD3-
CD 16 + CD56+ phenotype, however, CD16- (approxi-
mately 5 % ) or CD56- NK cells can also be detected 
(Timonen et al., 1979; Trinchieri and Perussia, 1984; 
Zarcone et al., 1987a). 
Both CTL and NK/LAK cells kill their targets by 
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a multistage mechanism that is initiated by the binding 
of the effector cell to the target cell (conjugate forma-
tion). Binding is accompanied by a rearrangement of 
cell surface microvillar structures (Liepins et al., 1977; 
Carpen, 1987; Arancia et al., 1991a) and cytoskeletal 
structures (polarization toward the target) followed by 
the activation of the effector cell and the release of 
molecules (e.g., perforins) in the intercellular space ca-
pable of inducing the target cell lysis (Plaut et al., 1973; 
Strom et al., 1973; Rayser et al., 1982). In this space, 
the cell adhesion molecules (CAMs) such as LFA-1 
(CD 1 la/CD 18) and CD2, could easily interact with cor-
responding molecules in the target cell [e.g., ICAM-1 
(CD54) and LFA-3 (CD58)] (Martz, 1987; Patarroyo et 
al., 1990; Zarcone et al., 1992a). The LFA-1 protein is 
a member of the integrin family that binds to the 
ICAM-1 and ICAM-2 molecules, members of the immu-
noglobulin super-family, expressed in a wide variety of 
cells from different tissues (Selvaraj et al., 1987; Boyd 
et al., 1988). Binding of LFA-1 to ICAM, in addition 
to the CD2-LFA-3 interaction, induces antigen-independ-
ent adhesion between effector and target cell (Springer 
et al., 1987; Shaw and Shimizu, 1988; Springer, 1990). 
It has been suggested that the contact region be-
tween conjugated cells, with the formation of a so-called 
"closed chamber", might have an important role in the 
activity of effector cells by modulating their efficiency 
(Sung et al., 1986, 1988; Malorni et al., 1989; Arancia 
et al., 1989, 1991a). During T cell-target cell interac-
tion, the LFA-1 molecules co-migrate to the site of cell-
cell contact with the TcR molecules, but a direct binding 
of LFA-1 and the TcR complex has not been demon-
strated (Shaw and Luce, 1987; Takai et al., 1987). As 
mentioned above, the CD2 glycoprotein on the surface 
of thymocytes and T lymphocytes binds to the lympho-
cyte function antigen (LFA-3) on target cells and anti-
gen-presenting cells. It has been suggested that the 
physical association of CO2 and TcR complex can likely 
be required for T cell triggering (Selvaraj et al., 1987; 
Takai et al., 1987). Furthermore, the intimate contact 
resulting from such an interaction system seems to be in-
volved in the mechanism of cytotoxicity by improving 
the "efficiency" of cytotoxic factors produced by 
immune effectors and released in the contact region 
(Podak, 1985; Clark, 1988; Stanley and Luzio, 1988; 
Arancia et al., 1990). 
In order to evaluate the role of the closed cham-
ber features in the killing efficiency, a study has been 
performed on cell surface and cytoskeleton of conjugates 
formed between different effector cells and various tu-
mor targets, by means of fluorescence microscopy and 
scanning electron microscopy. In addition, a quantita-
tive morphometric analysis has been carried out on the 
structural characteristics of such a contact region. The 
effect of antibodies against CAMs has also been evalu-
ated in order to establish their involvement in the closed 
chamber formation and related killing activity. Results 
obtained clearly provide a general indicative method for 
the evaluation of the cell-to-cell interaction in cell medi-
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ated immunity and seem to be suggestive for a key role 
of adhesion molecules, not only in the binding process, 
but also in the activation mechanisms. 
Materials and Methods 
Cytotoxic effector cells 
Several effector cell preparations were used in 
this study. Peripheral blood lymphocytes (PBL) were 
isolated from heparinized blood samples of normal adult 
donors by Ficoll-Hypaque density gradient centrifugation 
and depleted of monocytes by Percoll gradient centrifu-
gation. Cytochemical staining for acid esterase activity 
showed that monocyte contamination of PBL preparation 
was always less than 3 % . PBL were used as effector 
cells for the determination of NK cell-mediated cytotox-
icity. For the generation of LAK cells, PBL were cul-
tured for 3 days in RPMI 1640 (with 10% fetal calf 
serum and 50 µg/ml gentamycin) containing 100 IU/ml 
Interleukin 2 (IL-2) (Biogen, Lausanne, Switzerland). 
For the scanning electron microscopy (SEM) anal-
ysis of conjugates formed between effector cells and 
tumor cell targets (see below) we used purified popula-
tions of NK cells and of LAK cells. To this end, freshly 
isolated or IL-2-cultured PBL were allowed to form high 
affinity E rosettes, at 29°C, with untreated sheep eryth-
rocytes. Non-rosetting cells were recovered by Ficoll-
Hypaque density gradient centrifugation and incubated 
with a mixture of anti-CD3 and anti-CD2 mouse mono-
clonal antibodies. Cells were subsequently admixed with 
immunobeads coated with goat anti-mouse immunoglob-
ulin (Dynabeads, Oxoid, Unipath, Milano) at a bead to 
cell ratio of 40 to 1. Cells which did not adhere to the 
beads were recovered and the percentage of NK cells 
was evaluated by flow cytometry (FACScan, Becton 
Dickinson, Mountain View, CA), following staining with 
anti-CD 16 or CD56 antibodies and affinity purified, 
FITC-labelled goat anti-mouse immunoglobulin anti-
serum (Southern Biotechnology Associates, Birmingham, 
AL). Purified populations of NK and LAK cells always 
contained > 80% CD16+ cells. 
Tumor target cells 
The NK-sensitive erythroleukemic cell line K562 
(Landay et al., 1987) was used in all of the experiments. 
To determine LAK activity, we used a variant of the 
promyelocytic cell line HL60, HL60R, which does not 
bind NK cells and consequently is NK-resistant (Zarcone 
et al., 1987b). This cell line was also used as a control 
for the effector to target cell binding experiments. 
Antibodies 
NK cells, defined as CD16+ cells, and their IL-2-
activated progeny were enumerated by FACS analysis 
using FITC-labelled Leu 11 b antibodies (Becton 
Dickinson). The same antibody was employed to deter-
mine the binding of CD16+ cells to tumor targets. 
Other antibodies used in these studies were directed 
against CD2 (Leu 5b), CD3 (Leu 4) and CD56 (Leu 19) 
(all from Becton Dickinson). The anti-LFAl (CD l la/ 
CD18) antibody was selected among several anti-LFA-1 
Non-MHC restricted cell-mediated cytotoxicity 
monoclonal reagents produced in our laboratory for its 
ability to determine maximal inhibition of NK cell-
mediated cytotoxicity. 
Cytotoxicity assays 
NK activity was measured as the ability of fresh 
PBL to lyse K562 cells. LAK activity was determined 
using IL-2-cultured PBL against K562 cells or the NK-
resistant cell line HL60R. NK and LAK cell-mediated 
cytotoxicity was determined in five distinct experiments. 
The lytic function (cytotoxicity) of 30 CD3- clones was 
tested against K562 cells. Target cells were labelled 
with Sier by incubation with 200 µCi of Nas 1cro 4 
(Amersham International, Buckinghamshire) for 1 hour 
at 37°C, as described (Zarcone et al., 1989). Effector 
cells were admixed with target cells at 40: 1 ratio for NK 
and LAK cells and at 20: 1 ratio for CD3- cell clones. 
Cell mixtures were incubated for 4 hours at 37°C in 
round-bottomed 96 well microtiter plates and centrifuged 
at 200 rpm for 5 minutes at the end of the incubation pe-
riod. After centrifugation, 100 µl of supernatant were 
harvested from each well and counted in a gamma 
counter. 
Spontaneous release, maximum release and % 
specific Sier release were determined as previously 
described (Tilden et al., 1991). 
The effect of antibodies to CD16, CD56, CD2, 
CDl la and CD2+CDl la on the cytotoxicity mediated 
by NK cells, LAK cells and CD3- cell clones was deter-
mined through the decrease of specific Sier release and 
expressed as % inhibition. Target cells were added to 
the effector cells at the ratios indicated above and the 4 
hour cytotoxicity assay was performed in the presence of 
the antibodies. 
Flow cytometric determination of NK/LAK cell 
binding to tumor target cells 
Percentages of CD16+ cells in freshly isolated 
or IL-2-cultured PBL were determined by flow cytometr-
ic analyses after staining with FITC-labelled monoclonal 
antibody (mAb) of IgM isotype (Leu 1 lb). Cells were 
subsequently allowed to form conjugates with tumor 
cells for an immunofluorescence binding assay. Briefly, 
PBL were admixed with tumor cells (K562 or HL60R) at 
5: 1 ratio and cell pellets obtained by centrifugation at 
200 rpm were incubated for 10 minutes at 37°C. Pellets 
were gently resuspended and analyzed by FACS. Dot 
plot analyses showed two distinct cell populations con-
sisting of unbound lymphocytes and of target cells (with 
or without bound lymphocytes), respectively. Gates 
were set on the unbound lymphocyte populations and 
percentages of CD 16 + cells were determined. The ex-
tent of effector to target cell binding was indicated by 
decrease in the percentage of CD 16 + cells among un-
bound lymphocytes. Thus, percentages of conjugate-
forming CD 16+ cells could be calculated. As a control 
for the assay, we used the HL60R cell line, previously 
shown to be unable of binding NK cells (Zarcone et al., 
1987b). 
The effect of anti-adhesion molecule antibodies 
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was tested using the same assay. Effector cells were 
separately incubated with anti-CD2, anti-CDl la/CD18 
or anti-CD56 (10 mg protein/10 6 cells), or with mixtures 
of these mAb, for 30 minutes on ice. Target cells were 
subsequently added and the binding assay was performed 
for 5 minutes at room temperature. Negative controls 
were performed by using anti-Leu 19 (CD56) and anti-
Leu 11 (CD16), IgG l isotype (about 0.1% inhibition). 
Scanning electron microscopy (SEM) analysis 
For SEM analysis, conjugates between effector 
and target cells were seeded on polylysine-coated cover-
slips. After a few minutes, to allow adhesion to the 
glass surface, cells were fixed with 2.5 % glutaraldehyde 
in O. lM cacodylate buffer (pH 7.4) at room temperature 
for 20 minutes, post-fixed with 1 % OsO4 in the same 
buffer, dehydrated through a graded ethanol series, criti-
cal-point dried with CO2 and gold-coated by sputtering. 
Samples were examined with a Philips 515 scanning 
electron microscope. 
Fluorescence microscopy analysis 
Samples were applied to polylysine-coated glass 
slides and fixed in 3 .5 % formaldehyde for 20 minutes at 
room temperature. After washing in PBS buffer, the 
cells were permeated with 0.5% Triton X-100 (Sigma T-
6878) in the same buffer for 5 minutes at room tempera-
ture. For actin detection, cells were stained with fluo-
rescein-phalloidin (NBD-phallacidin, Molecular Probe) 
(final dilution 1:100 in PBS) at 37°C for 30 minutes. 
For tubulin labelling, incubation with a mixture of 
monoclonal anti-alpha and anti-beta tubulin antibodies 
(Amersham) (final dilution l :500 in PBS) at 37°C for 30 
minutes were performed. Washed cells were then incu-
bated with a sheep anti-mouse IgG fluorescein-linked 
whole antibody (Amersham, final dilution 1 :20 in PBS). 
After washing coverslips were mounted with glycerol-
PBS (2: 1) and analyzed with a Nikon Optiphot fluores-
cence microscope. 
Quantitative evaluation of the conjugates contact area 
In order to evaluate the extent of the contact area 
between effector cells (NK, LAK) and different target 
cells (K562, HL60R) conjugates were examined by 
SEM. About 50 micrographs at the same magnification 
(6500x) were taken for each sample. Measurements 
were performed either on control conjugates or on cell 
pairs after exposure to antibodies to CD2 and CD l la/ 
CD18. Before recording every picture, the specimen 
was tilted to put the axis of the cell pair perpendicular to 
the detector in order to avoid the overlapping of the two 
cell types. The length of the contact region was 
determined by an interactive image analyzer (IBAS II, 
Kontron), measuring the distance between the limit 
points of the adhesion area between effector and target 
cells. The contact area was calculated by roughly as-
suming it circular in shape. The mean values and the 
relative standard deviations were then calculated for 
each sample. The significance of the difference between 
the mean values recorded in control and MoAbs-treated 
conjugates was evaluated by Student's T test. 
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Results and Discussion 
Previous studies (Arancia et al., 1989, 1991 a) 
showed that cytotoxic lymphocytes can exert a powerful 
lytic activity when a wide and intimate contact area is 
established with the target cell. Such a close interaction 
leads to the formation of the so-called "closed chamber" 
between effector and target cell, in which the various 
lytic factors find ideal conditions for enhancing their 
lethal potential (Zychlinsky et al., 1988; Arancia et al., 
1991a). This was also supported by morphological stud-
ies performed by comparing the interaction of effector 
c~l_ls with tar~et cells displaying different NK suscepti-
bility (Arancia et al., 1989, 1991a). In fact, in conju-
gates form~d with sensitive target cells, the cell pair 
contact reg10ns appeared to be large and characterized 
by the presence of numerous intertwined protrusions; 
conversely, when resistant target cells were employed, 
the contact area appeared to be narrow and no significant 
involvement of the cell surface structures could be de-
tected (Carpen 1987; Kang et al 1987; Arancia et al 
199 la). Furthermore, if NK-resistant target cells form-
ing a weak contact with NK cells, were conjugat;d with 
LAK cells, an increased interaction surface was 
revealed. 
We report here data obtained using two different 
tumor targets: the NK-sensitive K562 cell line and the 
NK-resistant, LAK-sensitive, HL60R cell line. The con-
tact area between effector and target cells has been stud-
ied by SEM and a quantitative evaluation of the exten-
sion of the contact region has been carried out. Such an 
analysis revealed that a close interaction occurred be-
tween effector and target cells in both experimental con-
jugates examined: NK/K562 and LAK/HL60R (Figs. la 
and lb, respectively). Furthermore, the quantitative 
evaluation showed that no significant difference occurred 
between the two different cell pairs. In fact, the average 
length of the closed chamber in NK/K562 conjugates was 
about 4.01 µm with respect to 3.53 µm measured in 
LAK/HL60R pairs (Fig. 2). The cell contact area was 
calculated by assuming it to be circular and smooth. 
However, it is known that the cell surface of both ef-
fector and target cells is characterized by numerous in-
tertwined microvilli and invaginations in the contact re-
gion. Thus, it is not possible to measure the real extent 
of the adhered cell membranes. 
Several studies have been carried out to investi-
gate the involvement of the cytoskeletal components in 
the binding and killing processes (Plaut et al. 1973· 
Sirianni et al., 1988; Malorni et al., 1989; Ar~ncia e~ 
al., 1991a). In fact, the configuration of the intercel-
lular space between effector and target cell also depends 
on the cytoskeletal arrangement of both cell types. In 
particular, the binding of the NK or LAK cells to the 
target ~el!s depends on microfilaments, whereas target 
cell lys1s 1s known to require microtubule assembly and 
rearrangement in both effector and target cells (Kupffer 
et al., 1983; Kupffer and Dennert, 1984; Sirianni et al., 
1988; Arancia et al., 1991a). In this context, the role of 
the target cell in the interaction with the effector cell has 
also to be evaluated. An "induced suicide" model has 
been suggested by Ucker (1987) who hypothesized a sui-
cide pro~ram that can be activated in the target cell by 
several different stimuli. Other authors also focused on 
the possibility of the target cell playing a direct role in 
its own death (Russel, 1983; Goldstein, 1987; Pitsillides 
et al., 1988; Chayen et al., 1990). Thus, different sus-
ceptibilities found in the tumor target cells could also 
depend on a different suicide program and different 
degree of "permissiveness" in allowing their death 
(Suthanthiran et al., 1984; Kramer and Simon, 1987). 
Moreover, these data indicated that the target cell con-
tributes actively in determining the formation of an ex-
tended and intimate contact with the killer cell (Kang et 
al. 1987; Arancia et al., 1991a). The changes occurring 
in cytoskeletal elements of target cell seem to support 
the challenging opinion of an induced suicide mecha-
nism. In fact, the lytic process seems to occur different-
ly in the conjugated target cells studied by an ultrastruc-
tural SEM analysis. A cell surface phenomenon, known 
as b!e_bbing, is easily appreciated in K562 cells, highly 
sens1t1ve to NK activity (Fig. 3a). By contrast, the NK-
resistant HL60R cells, even though recognized and 
bound by effector cells, undergo surface smoothing and 
appear to be simply adjacent to the killer cells (Fig. 3b). 
Blebbing process, widely recognized as a peculiar mark-
er of injured or dying cells, was usually associated with 
ion deregulation and free radical formation (Allen, 1987; 
Bellomo et al., 1990; Malorni et al., 1991a). The find-
ing that OH scavengers inhibit NK cell activity, suggest-
ed that OH, possibly generated via the lipooxygenase 
pathway of arachidonic acid metabolism, can contribute 
directly to target cell lysis or to being generated in the 
inter-plasma membrane space between target cells and 
effector cells (Suthanthiran et al., 1984). These data 
can also be related to recent results which involve target 
cell triggering by exogenous mechanisms (Di Virgilio et 
al., 1990). However, dying target cells showing differ-
ent sensitivity to immune effectors exhibit different mor-
phological features which could probably be further im-
portant markers of cell behaviour in terms of susceptibil-
ity (Liepins et al., 1977; Arancia et al., 1989). This 
could also depend on the availability of different targets 
to be "turned on" in their "suicide program"-cascade. 
To evaluate the role played by the adhesion mole-
cules in the formation of the closed chamber and to veri-
fy if the cell-to-cell interaction could be modified by 
altering CAM function, the NK and LAK cells were in-
cubated with anti-CD2 or anti-LFA-1 monoclonal anti-
bodies (alone or in association) before conjugation with 
the different target cells. In fact, some studies hypothe-
sized that antibodies to CAMs expressed on the target 
cells or on the effector cells inhibit, to a variable extent, 
the target cell lysis induced by both CTL and NK/LAK 
cells (Robertson et al., 1990; Springer, 1990; Van 
Seventer et al., 1990). The general hypothesis on the 
n:iechanism of such inhibition was that it depends prima-
nly on a reduced binding, i.e., pair number, or to an al-
tered conjugate formation, i.e., an impairment of inter-
K 562 
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Figure 1. NK/K562 (a) and LAK/HL60R (b) conjugates 
observed by SEM. In both cases, a wide and intimate 
contact region is established between effector (to the 
right) and target cells (to the left). Bars = 10 µm (Fig. 
la) and 5µm (Fig. lb). 
Figure 2. Scheme showing the average length of the 
contact region in the various cell pairs examined. In 
both cell conjugates (NK/K562 and LAK/HL60R) the ex-
tent of the cell-to-cell contact appears to be significantly 
reduced after treating the effector cells with anti-CD2 
and anti-CD l la/CD 18 monoclonal antibodies. 
Figure 3. Morphological aspects of the target cell death 
after binding with NK cell. K562 cells, highly sensitive 
to NK activity, undergo lysis by showing an evident sur-
face blebbing phenomenon (a). In NK-resistant HL60R 
cells the surface blebbing was not observed and the 
dying cells showed a surface smoothing with a complete 
loss of microvilli (b). Bars = 10 µm (Fig. 3a) and 5µm 
(Fig. 3b). 
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cellular contact. In our experience, when LAK cells 
were incubated with anti-CAM antibodies before conju-
gation with the target cells (HL60R), most cell pairs 
showed a modification of the closed chamber features re-
sulting in a remarkable reduction and narrowing of con-
tact surface which became sometimes "punctiform" (Fig. 
4). In particular, a reduction of effector cell cytotoxici-
ty, but not of binding, was detected after exposure to 
anti-CAMs either if administered solely or in combina-
tion. However, when treatment was performed with 
both antibodies the effector cell function appeared even 
more impaired (Table 1). The same effect was obtained 
in NK-K562 conjugates, albeit to a lesser extent. 
The quantitative morphometric evaluation per-
formed on SEM images showed statistically significant 
differences between control and antibody treated samples 
(Fig. 2). In particular, in NK-K562 conjugates the aver-
age cell contact area appears to be reduced of about one 
haif after preincubation of effector cells with anti-CD2 
and anti-LFA-1 antibodies. In LAK-HL60R conjugates 
this effect was even more evident, the cell contact area 
resulting to be about one third in antibody-treated sam-
ples when compared to control ones (Fig. 5). 
Results obtained seem to suggest that both CD2 
and LFA-1 play an important role in the mechanism of 
interaction and that the combined action of these two 
surface molecules contributes to the formation of a wide 
"closed chamber" between effector and target cell, prob-
ably improving killing ability. In fact, the pretreatment 
of both resting and IL-2-activated NK cells with anti-
bodies to LFA-1 and CD2, alone or in combination, ap-
peared to yield the highest level of inhibition. However, 
there are large differences in the level of inhibition 
which appear to be related to the degree of target cell 
sensitivity to NK/LAK cells. In conciusion, the killing 
process, rather than binding, seems to be a CAM-de-
pendent phenomenon. 
Treatment of NK and LAK cells with antibodies 
to CD2 and LFA-1 produces modifications only in the 
microtubule network when compared to control effector 
cell/target cell pairs. In fact, actin microfilaments 
appear to be marginalized in both control (Fig. 6a) and 
MoAbs exposed effector cells (Fig. 6b). In contrast, mi-
crotubular apparatus appears to be polarized toward tar-
get cell in control conjugates only (Fig. 6c), whereas it 
appears to be diffuse in pairs from MoAbs exposed ef-
fectors (Fig. 6d). These data are in accord with the 
functional results above mentioned and strongly suggest 
a role of adhesion molecules not merely in the binding 
process but in the killing too (Bierer et al., 1989; Figdor 
et al., 1990; Makgoba et al., 1988, 1989; Springer, 
1990; Van Seventer et al., 1990). The changes in the 
cytoskeletal arrangement observed in the effector cell 
treated with MoAbs, after binding with the target cell, 
seem in fact to contribute to both the important aspects 
of the cytotoxic mechanism: the formation of a close 
cell-to-cell contact between effector and target cell but, 
most of all, the delivery of the lytic substances against 
the target cell. 
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Discussion with Reviewers 
E. de Harven: Was the effect of antibodies demon-
strated to be dose-dependent, and what irrelevant anti-
bodies were used as controls in these experiments? 
Y .H. Kang: The authors do not mention how much of 
each antibody was used to inhibit the cytotoxicity of NK 
cells and LAK cells. The authors also did not address 
whether the inhibition by the antibodies is dose-related. 
Authors: Antibody concentrations were those used in 
immunofluorescence assays for staining cells, i.e., 10 
mg protein/ 106 cells. More importantly, this concentra-
tion represents the plateau dose for efficient inhibition of 
cytotoxicity. Negative controls were performed by using 
anti-Leu 19 (CD56) and anti-Leu 11 (CD16), IgGl iso-
type (about 0.1 % inhibition). 
E. de Harven: You appropriately described cell-medi-
ated cytotoxicity as a multistep process. Surprisingly, 
the time factor is barely mentioned in your experiments. 
Are the "conjugates" observed by SEM 2, 10, 30 or 120 
minutes after the effector cells (NK or LAK) have had 
an opportunity to make contact with the target cells? 
Admittedly, it is difficult to precisely synchronize the 
encounter between effector and target cells. However, 
if all the SEM observations are made at one arbitrarily 
chosen time after conjugation, please explain the ration-
ale for such a static approach to the study of a dynamic 
cell-cell interaction process. 
Authors: The binding phase occurs in seconds to min-
utes, the killing phase in minutes to hours. We think 
W. Malorni et al. 
that a time course study would be interesting but not 
useful considering the ability of the effectors to "re-
cycle" themselves continuously to kill their targets. In 
our opinion, such a study would refer to the conjugation 
process per se. Different incubation times (30 minutes, 
1, 2 and 4 hours) were in fact used. Unfortunately, con-
jugate formation, once it is occurring, proceeds continu-
ously. 
L.H. Graf: Under the experimental conditions em-
ployed, CD2 and LFA-1 of the effector cells do not 
seem to contribute in a major way to the formation of 
the observed conjugates. In the case of the temperature-
and Mg2+ -dependent formation of conjugates between 
ICAM-1 and LFA-1 (Mac-1), the incubation conditions 
(room temperature, unspecified Mg2+ concentration) 
might be a factor. Information about the percents of 
CD16+ cells involved in the conjugates in the absence of 
antibodies (Abs) would be useful, as the possibility that 
the experimental conditions are not permitting a physio-
logically critical component of effector to target recogni-
tion to occur, hence allowing only "backup" adhesion 
mechanisms to be studied, must be considered. 
E. de Harven: Cells were incubated with anti-adhesion 
molecule antibodies for one hour at room temperature. 
How much of these Abs/CAM complex is already inter-
nalized at that time? And, if most of these complexes 
are already internalized, how could the CAM molecules 
still be determinant facts in the subsequent binding 
assays you performed? 
Authors: In the conjugate formation assay and in order 
to determine the effect of antibodies, we proceeded as 
follows: Effector cells were incubated with antibodies 
to CD2 and LFA-1 for 30 minutes on ice and subse-
quently mixed with target cells. The target-effector mix-
ture was pelleted and incubated at room temperature for 
5 minutes. The mixture was resuspended and conjugates 
were counted. In these conditions, the percentage of 
conjugate-forming cells was unchanged as compared to 
controls. Our observations according to the literature 
data indicate that 50- 70 % of CD 16-positive cells are 
capable of forming a conjugate with K562 cells under 
the experimental conditions describe above (see also 
Zarcone et al., 1992). We also agree that several other 
ligand-receptor pairs may influence the binding of ef-
fectors to target cells as is also suggested by our recent 
studies (Zarcone et al., 1992). 
Y .H. Kang: Which target or tumor cells express CD54? 
Authors: We refer you to Table 1 in Zarcone et al. 
( 1992) for the expression of adhesion molecules on 
tumor cell targets. 
Y .H. Kang: Do some tumor tissues also express inte-
grins? If so, what cells? 
Authors: For this important question, please refer to 
papers by R.O. Hynes (Hynes, 1987, 1992). 
Y .H. Kang: How were NK cells purified? Which NK-
332 
speci fie antibodies were used? 
Authors: NK cells were purified by negative selection 
using B and T cell depletion with anti-CD3 and CD19 
antibodies following treatment with complement or mag-
netic beads. Monocytes were previously eliminated by 
Percoll gradients. 
Y .H. Kang: What is the definition of "closed cham-
ber"? Is this term created by the authors based on their 
own ultrastructural observations? Ultrastructure of the 
NK-K562 conjugates does not really reveal that the con-
tacts between NK cells and K562 target cells form a 
chamber-like structure. 
Authors: The term "closed chamber" was used in order 
to define the contact region between effector cells and 
target cells. In this region, a wide intertwining of mi-
crovillous structures leads to the formation of a sort of 
chamber in which perforins as well as other "cytotoxic" 
factors can easily reach the target cell with minimal dis-
persion in the environment. We think that SEM analysis 
can provide useful information about this region. Kang 
et al. (1987) have used transmission electron microscopy 
(TEM) to analyze effector-target cell conjugates. Under 
these circumstances only a study of serial sections may 
define the existence, or not, of a closed chamber. Oth-
erwise, the effector/target cell contacts are selected at 
random. 
Y .H. Kang: The authors assume that the contacts be-
tween effector and target are circular. How did the 
authors derive such an assumption? 
Authors: We think that two spherical cells could only 
interact by forming a round-shaped contact area, as 
revealed by SEM or light microscopy (including confo-
cal microscopy). Only serendipity could provide such an 
image in a singe section in a TEM (see Liepins et al., 
1977, or Carpen, 1987). 
Y .H. Kang: The authors intend to correlate their obser-
vations on the alterations in the organization of actin 
filaments and microtubules in both effector cells and tar-
get cells with the lytic process. The reorganization of 
actin filaments is known to be regulated by surface inte-
grins. The authors do not mention the effect of the anti-
CAM antibodies (anti-LFA-1) on the reorganization of 
actin filaments. In this respect, does anti-ICAM-1 anti-
body affect the reorganization of the cytoskeleton and 
result in impairment of "close chamber" formation and 
killing? ICAM-1 is a specific ligand for LFA-1 
receptor. 
Authors: Papers by Kupffer and colleagues, e.g., 
Kupffer et al. (1989), and by our group (Arancia et al., 
1985, 1989, 1991a, 1991b; Malorni et al., 1987, 1989, 
1991b; Sirianni et al., 1988; Zarcone et al., 1992a, 
1992b) have tried to approach this question of "dynamic 
changes" occurring in two cells capable of binding them-
selves and interacting so closely. 
